Compare PYPD & CLWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PYPD | CLWT |
|---|---|---|
| Founded | 2008 | 1971 |
| Country | Israel | Hong Kong |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Professional and commerical equipment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.0M | 12.0M |
| IPO Year | 2014 | 1996 |
| Metric | PYPD | CLWT |
|---|---|---|
| Price | $5.17 | $1.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $12.25 | N/A |
| AVG Volume (30 Days) | ★ 109.2K | 12.8K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $17.56 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.06 | $0.99 |
| 52 Week High | $5.73 | $2.68 |
| Indicator | PYPD | CLWT |
|---|---|---|
| Relative Strength Index (RSI) | 53.88 | 41.05 |
| Support Level | $4.15 | $1.44 |
| Resistance Level | $5.64 | $1.74 |
| Average True Range (ATR) | 0.25 | 0.08 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 34.41 | 18.64 |
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
Euro Tech Holdings Co Ltd is mainly a distributor of a wide range of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies, and power generation equipment, including recorders and power quality analyzers. The Company acts as an exclusive or non-exclusive distributor for manufacturers of such equipment to commercial customers and governmental agencies in Hong Kong and mainland China, as well as commercial customers in Macau. It has two operating segments: Trading and manufacturing, which generate maximum revenue and act as a distributor of water treatment equipment, laboratory instruments, analyzers, test kits, related supplies, and power generation equipment; and the Engineering segment. The Company generates maximum revenue from the PRC.